# Spiration

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spiration

- Industry: Medical Devices & Equipment
- Headquarters: Redmond, US
- Website: www.spiration.com
- Total disclosed funding: $81M
- Latest round: Series G (Mar 21, 2008)
- Investors on record: 9

## About

Spiration, Inc. is a medical technology company focused on developing innovative treatments for severe respiratory conditions, particularly utilizing the Spiration® Valve System to enhance lung function for patients.Founded in 1999 in Redmond, US, Spiration, Inc. specializes in advanced medical devices aimed at treating severe emphysema. The company was acquired by Olympus Corporation in June 2010, with its operations continuing under the Olympus brand. The current CEO is Rick Shea.Spiration, Inc. is renowned for the Spiration® Valve System, a minimally-invasive treatment designed for individuals suffering from severe emphysema and Alpha-1 Antitrypsin Deficiency. This system utilizes endobronchial valves to improve lung function, significantly reducing shortness of breath and enhancing users' quality of life. The valves are implanted during a bronchoscopy procedure, typically taking under two hours, and are designed for permanence with possible removal. Their primary clientele includes healthcare providers and pulmonologists across the United States and select European markets.Spiration, Inc. generates its revenue through business-to-business transactions with healthcare facilities that purchase the Spiration Valve System for medical procedures. Revenue is derived from the sales of individual valves, often accompanied by training and support services for healthcare providers. The financial success of the company is closely linked to the adoption rates of the Spiration Valve System, particularly in hospitals specializing in chronic obstructive pulmonary disease (COPD) and emphysema treatment.Spiration, Inc. aims to expand its product offerings and enter new international markets. The company is focused on developing additional innovative solutions to enhance patient care, leveraging the recent USD 6.50 mn raised in the latest Venture Debt funding round to support these initiatives. By strategically targeting additional regions in Europe and increasing its market presence in the United States, Spiration plans to broaden its reach and enhance the availability of its services by the end of 2015.

## Funding rounds

- Series G, Mar 21, 2008, $19M — InterWest Partners, New Enterprise Associates, Versant Ventures, Three Arch Partners, New Leaf Venture Partners, Patricia Industries, Olympus Corporation
- Series F, Apr 3, 2006, $13M — InterWest Partners, New Enterprise Associates, Sprout Group, Versant Ventures, Three Arch Partners, Patricia Industries, Olympus Corporation, Guidant Corp.
- Series E, Jan 6, 2004, $27M — InterWest Partners, New Enterprise Associates, Sprout Group, Versant Ventures, Three Arch Partners, Patricia Industries, Guidant Corp.
- Series D, Jun 18, 2002, $22M — New Enterprise Associates, Sprout Group, Versant Ventures, Three Arch Partners

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series D, Series E, Series F, Series G
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series D, Series E, Series F
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series D, Series E, Series F, Series G
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series D, Series E, Series F, Series G
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series E, Series F, Series G
- Patricia Industries (https://capitalatlas.ai/funds/patricia-industries) — Series E, Series F, Series G
- Guidant Corp. — Series E, Series F
- Olympus Corporation — Series F, Series G
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series G